Paulsen et al. 22 evaluated disease-specific survival (DSS) and reported that low tumor epithelial expression of PD-L1 had a significant negative prognostic impact on DSS in SCC patients, while PD-L1 status was not associated with survival for patients with large cell carcinoma or ADC. The gene discussed is CD274; the disease is neoplasm.